Display Settings:

Format
Items per page

Send to:

Choose Destination

Results: 1 to 20 of 26

1.

Insulin resistance

Decreased sensitivity to circulating insulin which may result in acanthosis nigicrans, elevated insulin level or hyperglycemia. [from NCI]

MedGen UID:
43904
Concept ID:
C0021655
Pathologic Function
2.

Glucose

A hexose with an aldehyde group; in which each of the 5 remaining carbons other than the aldehyde group has one hydroxyl group in the R,S,R, and R configuration counting from the first hydroxyl containing carbon next to the aldehyde in the straight chain (Fisher) projection; otherwise all carbons have exclusively hydrogens. Occurs mostly as pyran (6-membered oxygen containing ring or oxane) and rarely as furan (5-membered oxygen containing ring) or straight chain. When glucose forms a ring an additional ""anomeric"" asymmetric carbon is created which is denoted as ""alpha"" or ""beta"". For isomers see http://en.wikipedia.org/wiki/Glucose. [from NCI]

MedGen UID:
42238
Concept ID:
C0017725
Pharmacologic Substance
3.

Insulin

Insulin (51 aa, ~6 kDa) is encoded by the human INS gene. This protein is involved in the direct regulation of glucose metabolism. [from NCI]

MedGen UID:
5827
Concept ID:
C0021641
Pharmacologic Substance
4.

Fasting

Abstaining from all food. [from MeSH]

MedGen UID:
5129
Concept ID:
C0015663
Finding
5.

Combined hyperlipidemia

MedGen UID:
833258
Concept ID:
CN205835
Finding
6.

Mixed hyperlipidemia

MedGen UID:
781171
Concept ID:
C2047520
Disease or Syndrome
7.

Hyperlipidemia

An elevated lipid concentration in the blood. [from HPO]

MedGen UID:
505446
Concept ID:
CN002774
Finding
8.

Insulin resistance

Increased resistance towards insulin, that is, diminished effectiveness of insulin in reducing blood glucose levels. [from HPO]

MedGen UID:
504630
Concept ID:
CN000801
Finding
9.

Hyperlipidemia, familial combined

APOE p.Leu167del is a rare genetic variant described in 38 cases in the literature with a range of clinical phenotypes. Three phenotypes can be associated with the APOE p.Leu167del variant: Inherited lipemic splenomegaly (also known as sea-blue histiocytosis) characterized by hypertriglyceridemia and splenomegaly. Variable manifestations include thrombocytopenia, liver function abnormalities, and cardiovascular disease. Autosomal dominant hypercholesterolemia (ADH) characterized by markedly elevated LDL cholesterol levels that leads to premature morbidity and mortality from atherosclerotic cardiovascular disease (ASCVD). Familial combined hyperlipidemia (FCHL) characterized by variable elevations of total cholesterol, triglycerides, or LDL cholesterol and a high risk of premature ASCVD. It has been suggested that the phenotype associated with the APOE p.Leu167del variant may depend on multiple factors, including sex, APOE genotype, control of hyperlipidemia, gene-gene interactions, gene-environment interactions, or perhaps epigenetic and other non-Mendelian effects. [from GeneReviews]

MedGen UID:
6965
Concept ID:
C0020474
Disease or Syndrome
10.

Lipidemia

Lipedema is a disorder of adipose tissue characterized by fat legs and orthostatic edema. Characteristically, the buttocks and other parts of the lower extremities are symmetrically enlarged owing to accumulation of excess fat and fluid. The condition affects women almost exclusively and, in most instances, represents an exaggeration of the female form (summary by Hines, 1952). [from OMIM]

MedGen UID:
5692
Concept ID:
C0020473
Disease or Syndrome
11.

Fenofibrat-ratiopharm

MedGen UID:
327863
Concept ID:
C1564834
Pharmacologic Substance
12.

Controlip

MedGen UID:
327836
Concept ID:
C1564718
Pharmacologic Substance
13.

Liparison

MedGen UID:
289899
Concept ID:
C1564727
Pharmacologic Substance
14.

durafenat

MedGen UID:
289896
Concept ID:
C1564719
Pharmacologic Substance
15.

Fenofanton

MedGen UID:
289029
Concept ID:
C1564744
Pharmacologic Substance
16.

Fenobeta

MedGen UID:
289028
Concept ID:
C1564743
Pharmacologic Substance
17.

MTW-Fenofibrat

MedGen UID:
289024
Concept ID:
C1564729
Pharmacologic Substance
18.

Livesan

MedGen UID:
289023
Concept ID:
C1564728
Pharmacologic Substance
19.

Gen-Fenofibrate

MedGen UID:
289022
Concept ID:
C1564726
Pharmacologic Substance
20.

Nu-Fenofibrate

MedGen UID:
257924
Concept ID:
C1170450
Pharmacologic Substance

Display Settings:

Format
Items per page

Send to:

Choose Destination

Supplemental Content

Find related data

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...